Biocon

Apr 29, 2016 at 17:44 | Source: Moneycontrol.com
Axis Securities is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 680 in its research report dated April 28, 2016.
Apr 29, 2016 at 17:43 | Source: Moneycontrol.com
ICICIDirect recommended hold rating on Biocon with a target price of Rs 544 in its research report dated April 28, 2016.
Apr 29, 2016 at 10:02 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that one may short Larsen & Toubro and feels that Reliance Industries may test Rs 967.
Apr 28, 2016 at 14:37 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying UPL and Biocon and advises selling IRB Infra.
Apr 27, 2016 at 12:56 | Source: PTI
Net sales rose to Rs 970.3 crore for the fourth quarter, up 16.84 percent, from Rs 830.4 crore a year ago, Biocon said in a BSE filing.
Apr 27, 2016 at 11:59 | Source: CNBC-TV18
Biocon R&D team is working on the second phase of the development of oral insulin, and Kiran Mazumdar-Shaw, Chairman & MD, Biocon, hopes that it becomes an approved product in the next 2-3 years.
Apr 27, 2016 at 11:45 | Source: CNBC-TV18
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com spoke about his outlook on the market and specific stocks.
Apr 27, 2016 at 09:24 | Source: CNBC-TV18
The banking space has rallied in the last two months helped largely by disclosures of bad loans. But the pain is not over yet for banks. It will last for two quarters at least, says Vaibhav Sanghavi, MD Of Ambit Investment.
Apr 27, 2016 at 08:35 | Source: CNBC-TV18
Here are a few stocks picked up by CNBC-TV18's analysts to keep on your radar for trade today - REC, NCC, Axis Bank, Bharti Infratel, Biocon, Synegene, Rallis, Maruti, Raymond, Gujarat Narmada Valley Fertilizers & Chemicals, Swaraj Engines, IDFC Bank & Agro Tech Foods.
Apr 26, 2016 at 22:08 | Source: PTI
The Delhi High Court has allowed pharma firms, Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd, to continue with manufacture and marketing of their breast cancer drug under their brand names 'CANMAb' and 'HERTRAZ'.
Messages on Biocon »

subs74

Silver Member

6 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

ScorpioKing
-KD

Gold Member

604 Followers

Biocon  

Any specific relation would have to seen in main budget - my point was that if overall market tanks badly - Biocon wont be exception. Not necessarily related to biocon. Long due correction in market.

3.52 PM Jul 8th 2014

subs74

Silver Member

6 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

namo8081

New Member

3 Followers

Biocon  

kal biocon 520 ke niche milega

2.56 PM Jul 8th 2014

dr.sachin

New Member

4 Followers

Biocon  

biocon has nothing to do with railway budget still creeping down

1.54 PM Jul 8th 2014

AgSa

New Member

1 Followers

Biocon  

may biocon taste 650 lvl by end aug14.

12.31 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

12943 Followers

Biocon  

Biocon Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.08 AM Jul 8th 2014

sanecounsel

Platinum Member

137 Followers

Biocon  

the outcome of the Delhi High Court case brought by Roche against Biocon and Mylan in February gains significance. Roche has alleged that Biocon/Mylan has misrepresented its drugs as a biosimilar of its bestselling breast cancer drug, Trastuzumab (Herceptin), without having undergone the required

10.04 AM Jul 8th 2014

niceworld

Platinum Member

6397 Followers

Granules India  

`t care because I do believe this and the results have been terrific till now in my life.There are many examples.Biocon was one of such examples... contd.

10.21 PM Jul 7th 2014

neo_ice

New Member

0 Follower

Biocon  

heavy buying seen at day`s end with high volumes .... brakout pattern from all time high also suggests eminent rise - My target for Biocon is Rs 580 for the short term

3.43 PM Jul 7th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.